Sotera Health Company SHC
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 14.76% | -7.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.76% | -7.71% | |||
| Cost of Revenue | 7.85% | -3.30% | |||
| Gross Profit | 21.01% | -11.36% | |||
| SG&A Expenses | -6.25% | 3.83% | |||
| Depreciation & Amortization | -0.53% | 0.26% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.58% | -1.26% | |||
| Operating Income | 39.34% | -19.30% | |||
| Income Before Tax | 83.16% | -39.55% | |||
| Income Tax Expenses | 52.32% | -55.05% | |||
| Earnings from Continuing Operations | 101.75% | -23.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 101.75% | -23.70% | |||
| EBIT | 39.34% | -19.30% | |||
| EBITDA | 31.07% | -15.94% | |||
| EPS Basic | 101.18% | -23.90% | |||
| Normalized Basic EPS | 75.41% | -34.15% | |||
| EPS Diluted | 108.56% | -24.81% | |||
| Normalized Diluted EPS | 75.70% | -34.03% | |||
| Average Basic Shares Outstanding | 0.31% | 0.22% | |||
| Average Diluted Shares Outstanding | 0.18% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||